Skip to content

Clinical trials

Completed Diabetic Nephropathies trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Status: Completed Country / region: Canada Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20061
20101
20112
20122
20131
20143
20152
20172
20192
20202
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Bayer3
Boehringer Ingelheim3
Pfizer3
Gilead Sciences2
Ottawa Hospital Research Institute2
AbbVie (prior sponsor, Abbott)1
Alessandro Doria1
CSL Behring1
Inversago Pharma Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies26
Diabetes Mellitus, Type 28
Renal Insufficiency, Chronic7
Kidney Diseases6
Diabetes Mellitus5
Hypertension3
Albuminuria2
Diabetes Complications2
Diabetes Mellitus, Type 12
Proteinuria2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.